Walker PR - Search Results

1

Phagocytic function of tumor-associated macrophages as a key determinant of tumor progression control: a review.

Lecoultre M, Dutoit V, Walker PR. Lecoultre M, et al. Among authors: walker pr. J Immunother Cancer. 2020 Dec;8(2):e001408. doi: 10.1136/jitc-2020-001408. J Immunother Cancer. 2020. PMID: 33335026 Free PMC article. Review.

2

Melanoma patients respond to a cytotoxic T lymphocyte-defined self-peptide with diverse and nonoverlapping T-cell receptor repertoires.

Dietrich PY, Walker PR, Quiquerez AL, Perrin G, Dutoit V, Liénard D, Guillaume P, Cerottini JC, Romero P, Valmori D. Dietrich PY, et al. Among authors: walker pr. Cancer Res. 2001 Mar 1;61(5):2047-54. Cancer Res. 2001. PMID: 11280765

3

Vaccination with a Melan-A peptide selects an oligoclonal T cell population with increased functional avidity and tumor reactivity.

Valmori D, Dutoit V, Schnuriger V, Quiquerez AL, Pittet MJ, Guillaume P, Rubio-Godoy V, Walker PR, Rimoldi D, Liénard D, Cerottini JC, Romero P, Dietrich PY. Valmori D, et al. Among authors: walker pr. J Immunol. 2002 Apr 15;168(8):4231-40. doi: 10.4049/jimmunol.168.8.4231. J Immunol. 2002. PMID: 11937585

4

Prevalent role of TCR alpha-chain in the selection of the preimmune repertoire specific for a human tumor-associated self-antigen.

Dietrich PY, Le Gal FA, Dutoit V, Pittet MJ, Trautman L, Zippelius A, Cognet I, Widmer V, Walker PR, Michielin O, Guillaume P, Connerotte T, Jotereau F, Coulie PG, Romero P, Cerottini JC, Bonneville M, Valmori D. Dietrich PY, et al. Among authors: walker pr. J Immunol. 2003 May 15;170(10):5103-9. doi: 10.4049/jimmunol.170.10.5103. J Immunol. 2003. PMID: 12734356

5

Tissue homing and persistence of defined antigen-specific CD8+ tumor-reactive T-cell clones in long-term melanoma survivors.

Le Gal FA, Widmer VM, Dutoit V, Rubio-Godoy V, Schrenzel J, Walker PR, Romero PJ, Valmori D, Speiser DE, Dietrich PY. Le Gal FA, et al. Among authors: walker pr. J Invest Dermatol. 2007 Mar;127(3):622-9. doi: 10.1038/sj.jid.5700580. Epub 2006 Oct 12. J Invest Dermatol. 2007. PMID: 17039243 Free article.

6

T-cell immunotherapy for malignant glioma: toward a combined approach.

Dietrich PY, Dutoit V, Tran Thang NN, Walker PR. Dietrich PY, et al. Among authors: walker pr. Curr Opin Oncol. 2010 Nov;22(6):604-10. doi: 10.1097/CCO.0b013e32833dead8. Curr Opin Oncol. 2010. PMID: 20739889 Review.

7

Exploiting the glioblastoma peptidome to discover novel tumour-associated antigens for immunotherapy.

Dutoit V, Herold-Mende C, Hilf N, Schoor O, Beckhove P, Bucher J, Dorsch K, Flohr S, Fritsche J, Lewandrowski P, Lohr J, Rammensee HG, Stevanovic S, Trautwein C, Vass V, Walter S, Walker PR, Weinschenk T, Singh-Jasuja H, Dietrich PY. Dutoit V, et al. Among authors: walker pr. Brain. 2012 Apr;135(Pt 4):1042-54. doi: 10.1093/brain/aws042. Epub 2012 Mar 14. Brain. 2012. PMID: 22418738

8

Immunotherapy for glioma: from illusion to realistic prospects?

Dietrich PY, Dutoit V, Walker PR. Dietrich PY, et al. Among authors: walker pr. Am Soc Clin Oncol Educ Book. 2014:51-9. doi: 10.14694/EdBook_AM.2014.34.51. Am Soc Clin Oncol Educ Book. 2014. PMID: 24857060 Free article. Review.

9

Immunotherapy of Brain Tumors.

Dutoit V, Migliorini D, Walker PR, Dietrich PY. Dutoit V, et al. Among authors: walker pr. Prog Tumor Res. 2015;42:11-21. doi: 10.1159/000436986. Epub 2015 Sep 4. Prog Tumor Res. 2015. PMID: 26376741 Review.

10

Immunotherapy of Malignant Tumors in the Brain: How Different from Other Sites?

Dutoit V, Migliorini D, Dietrich PY, Walker PR. Dutoit V, et al. Among authors: walker pr. Front Oncol. 2016 Dec 7;6:256. doi: 10.3389/fonc.2016.00256. eCollection 2016. Front Oncol. 2016. PMID: 28003994 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

249 results

Search Page